There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests
The popularity of GLP-1 weight-loss medications continues to soar—and their uptake is helping to push down obesity rates on a national scale—but a safe, evidence-based way off the drugs isn’t yet in clear view. An analysis published this week in JAMA Internal Medicine found that most participants in a clinical trial who were assigned to […]
Medicare announces price cuts for 15 prescription drugs, including Ozempic
The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy.
Ozempic Penis ‘Is a Thing’: Dr Terry Dubrow Announces and It’s the Antidote to ‘Buried Penis Syndrome’
Dr Terry Dubrow announced a new Ozempic-related disorder, which he called ‘Ozempic penis,’ where one’s member ‘looks bigger’ while taking the GLP-1 medication.
CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks
The government on Tuesday announced final prices for the second round of drugs negotiated by Medicare under the Inflation Reduction Act, including for Novo Nordisk’s blockbuster weight loss drugs Ozempic and Wegovy. The negotiated prices …
Postpartum Prescription of GLP-1 Drugs Has Increased Sharply, Study Finds
By mid-2024, the weight-loss drugs were prescribed for almost 2 percent of new mothers.
Alzheimer’s Clinical Trial Results, Sadly Running True to Form
There have been some interesting failures recently in Alzheimer’s trials. As long-time readers will know, I consider basically all Alzheimer’s drug trials to have failed to one degree or another, and particularly when it comes to clearing the “will improve patient’s lives in the real world without putting them at too much risk” hurdle. But […]
Americans are microdosing obesity drugs, driven by ‘thin is in’ marketing blitz
Weight-loss drugs are coming for a new kind of customer. “You don’t need to be obese to start a GLP-1,” reads an ad from a telehealth startup, the words scrawled in icing on a cake. Another one features a slender woman excited to lose a little weight before her wedding. Yet another says patients can […]
Stopping GLP-1 drugs before pregnancy linked to complications
Women who stop taking GLP-1 medications just prior to a pregnancy appear to be at higher odds for weight gain and complications, researchers said.
Confronting the Global Rise of Obesity and Cardiovascular Disease: The Role of GLP-1 RAs
Publication date: 2 December 2025 Source: JACC, Volume 86, Issue 22 Author(s): Erica S. Spatz
GLP-1 users to make up 35% of food and beverage sales by 2030: report
As more consumers take weight loss medications like Ozempic or Wegovy, companies will need to act fast if they want to adapt, according to Circana.